Emergency and Critical Care

Welcome to the Emergency and Critical Care Current Clinical Trials page!

If you would like more information about a study, or think you would like to enroll your pet, contact the person listed under the study.  You may also Contact Us at the CIC.

Canine Sepsis Study

Current Status: Active and enrolling.
Principal Investigator:  Lisa Powell, DVM
Contact: Dr. Lisa Powell, Phone: 612-625-5226 E-mail: powel029@umn.edu

This study is looking for dogs that are hospitalized in the Veterinary Medical Center to evaluate a possible new therapy to treat septic shock.  Please contact Dr. Powell for more information.

High Mobility Group B-1 Protein as a Diagnostic and Prognostic Tool in Canine Systemic Inflammatory Response Syndrome and Sepsis

Current Status: Complete.
Principal Investigator:  Kelly Hall, DVM
Contact: Dr. Kelly Hall, Phone: 612-624-6288 E-mail: wilke022@umn.edu

HMGB-1 is known to be involved in inflammatory processes in other mammal species (e.g., humans, mice).  HMGB-1 has been identified as a protein in inflammatory processes, including sepsis, arthritis and cancer. The goal of this study is to evaluate if HMGB-1 can be detected in normal canine patient serum and if it changes significantly in known inflammatory processes (e.g., sepsis) or other naturally occurring animal diseases.

For more information about emergency services and critical care at the Veterinary Medical Center, please click here .